Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

The Thing About Risk

January 23rd 2015, 3:09am

Article

There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk.

PARP Inhibitor Approved for BRCA-Positive Advanced Ovarian Cancer

December 20th 2014, 3:17am

Article

The Food and Drug Administration approves Lynparza (olaparib) for the treatment of women with BRCA-positive advanced ovarian cancer.

FDA Approves Avastin to Treat Ovarian Cancer

November 15th 2014, 1:55am

Article

The FDA approves Avastin in combination with chemotherapy for patients with platinum-resistant recurrent ovarian cancer, based on results of the phase 3 AURELIA trial.

Accuracy Matters When It Comes to Diagnosing Cancer

April 14th 2014, 9:00am

Article

Biomarkers can estimate cancer risk, screen for the disease and confirm a diagnosis.

Is Robot-Assisted Surgery the Best Treatment for Your Cancer?

December 8th 2013, 11:00am

Article

Patients should research both the surgeon and the technique when deciding on treatment.

Supreme Court Votes Against Human Gene Patents

September 18th 2013, 9:00am

Article

The U.S. Supreme Court decides against patents on human genes.

Risk Management: Living in the Past, Present and Future with Genetic Risk

March 13th 2013, 9:00am

Article

Knowing your risk of a genetic cancer means looking to the past, living in the present and planning for the future.

Treating and Managing Metastatic Disease

December 8th 2012, 11:00am

Article

Reasons for Hope: Options are available to keep disease at bay.

Calling Cancer's Bluff: Research in Vaccine Therapy for Cancer Is Paying Off

June 11th 2012, 9:00am

Article

Vaccines help the immune system uncover malignant cells.

Avastin Produces Results in Chemo-Resistant Ovarian Cancer

June 7th 2012, 9:00am

Article

To tackle platinum-resistant ovarian cancer, a French research group added Avastin (bevacizumab) to standard chemotherapy.